Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer.
Saved in:
| Title: | Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer. |
|---|---|
| Authors: | Klinkhammer H; Institute for Medical Biometry and Statistics, Philipps-University of Marburg, Marburg, Germany.; Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany., Spier I; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; National Center for Hereditary Tumour Syndromes, University Hospital Bonn, Bonn, Germany.; Hereditary Cancer Syndrome Center, ERN GENTURIS, Bonn, Germany., Perne C; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany., Hoffmann P; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany., Büttner R; Institute of Pathology, Cologne University Hospital, Cologne, Germany., Schröck E; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; Hereditary Cancer Syndrome Center, ERN GENTURIS, Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Redler S; Institute of Human Genetics, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany., Jahn A; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; Hereditary Cancer Syndrome Center, ERN GENTURIS, Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Franke M; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; Hereditary Cancer Syndrome Center, ERN GENTURIS, Dresden, Germany.; National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Möslein G; Surgical Center for Hereditary Tumors, BETHESDA Hospital Duisburg, Academic Hospital University of Düsseldorf, Duisburg, Germany., Kloor M; Department of Applied Tumor Biology, Heidelberg University Hospital, Heidelberg, Germany., Schmidt B; Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany., Vangala D; Outpatient Center for Hematology and Oncology, Cancer Center Bochum-Herne, Bochum, Germany.; Department of Human Genetics, Medical Faculty, Ruhr-University Bochum, Bochum, Germany., Nguyen HP; Department of Human Genetics, Medical Faculty, Ruhr-University Bochum, Bochum, Germany., Forstner AJ; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany., Steinke-Lange V; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; MGZ-Medical Genetics Center, Munich, Germany.; Hereditary Cancer Syndrome Center, ERN GENTURIS, Munich, Germany., Holinski-Feder E; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; MGZ-Medical Genetics Center, Munich, Germany.; Hereditary Cancer Syndrome Center, ERN GENTURIS, Munich, Germany., Hüneburg R; National Center for Hereditary Tumour Syndromes, University Hospital Bonn, Bonn, Germany.; Hereditary Cancer Syndrome Center, ERN GENTURIS, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Maj C; Centre for Human Genetics, University of Marburg, Marburg, Germany., Engel C; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany., Mayr A; Institute for Medical Biometry and Statistics, Philipps-University of Marburg, Marburg, Germany., Aretz S; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; National Center for Hereditary Tumour Syndromes, University Hospital Bonn, Bonn, Germany.; Hereditary Cancer Syndrome Center, ERN GENTURIS, Bonn, Germany. |
| Source: | JNCI cancer spectrum [JNCI Cancer Spectr] 2026 May 09; Vol. 10 (3). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2515-5091 |
|---|---|
| DOI: | 10.1093/jncics/pkag041 |
